MedTrace Logo

Improving Germline Testing in At-Risk Patients With Prostate Cancer

NCT05470036 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-01-16

Study results available
· View outcomes & findings →

Summary

A quality improvement initiative to improve rates of germline testing among men with prostate cancer through the use of an in-clinic educational session.

Conditions

Interventions

BEHAVIORAL

Educational intervention.

Educational intervention with trained educator on overview, rationale, implications, and risks and benefits of germline testing in prostate cancer.

Sponsors & Collaborators

Principal Investigators

  • Rana McKay, MD · UCSD

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-27
Primary Completion
2025-06-01
Completion
2025-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05470036 on ClinicalTrials.gov